Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Vitura Health.
RELATED STOCKHEAD STORIES
News
LAST ORDERS: A quick-fire look back at the Monday just gone.
Explainers
ASX Cannabis Stocks Guide 2022/23: Here’s everything you need to know
Health & Biotech
Weed Week: US looks to decriminalise cannabis and Victoria Greens say legal weed could mean $1.21bn in revenue
News
ASX September Winners: Markets crushed in September as Fed still pulls the strings
Health & Biotech
Weed Week: Greens push hard to legalise cannabis and Cronos has 3% of Aussie GPs on its platform already
News
Rise and Shine: What you need to know before the ASX opens
News
Closing Bell: Aussie coal stocks on power trip as EU crisis moves to Gazprom-1
News
ASX Small Caps Lunch Wrap: Who else is battling a bumpy ride today?
News
ASX August Winners Column: Cannabis could be making a comeback
News
Closing Bell: Small caps licked in 3% rout as pot stock delivers ASX-first pot stock dividend!
News
Pot stocks finally pay out: Cronos delivers the ASX’s first med-cannabis FY profit and dividend
News
ASX Quarterlies: Records tumble, targets achieved in good news for shareholders
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Quarterlies: From fintech to biotech, these small caps have delivered strong performances for shareholders
News
Top 10 at 10: These ASX stocks are dazzling in early trade
Health & Biotech
Cannabis play Cronos delivers record quarter with $18m in cash receipts, sets up for long-term market leadership
Health & Biotech